14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KPTI
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Karyopharm Therapeutics Inc. stock price up 4.47% on Tuesday
(Updated on Jun 11, 2024)

Sell candidate since May 21, 2024 Loss -9.82% PDF

The Karyopharm Therapeutics Inc. stock price gained 4.47% on the last trading day (Tuesday, 11th Jun 2024), rising from $0.97 to $1.01. During the last trading day the stock fluctuated 9.74% from a day low at $0.93 to a day high of $1.03. The price has been going up and down for this period, and there has been a 1.66% gain for the last 2 weeks. Volume fell on the last day by -303 thousand shares and in total, 554 thousand shares were bought and sold for approximately $559.68 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -31.43% during the next 3 months and, with a 90% probability hold a price between $0.607 and $0.794 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KPTI Signals & Forecast

There are mixed signals in the stock today. The Karyopharm Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.06. On a fall, the stock will find some support from the short-term average at $0.97. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Tuesday, June 04, 2024, and so far it has risen 8.95%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Karyopharm Therapeutics Inc. stock

Karyopharm Therapeutics Inc. finds support from accumulated volume at $0.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0910 between high and low, or 9.74%. For the last week the stock has had daily average volatility of 7.57%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KPTI) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Karyopharm Therapeutics Inc. to open at $0.99, and during the day (based on 14 day Average True Range), to move between $0.93 and $1.09, which gives a possible trading interval of +/-$0.0826 (+/-8.18%) up or down from last closing price. If Karyopharm Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 16.35% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.99 (1.54%) than the resistance at $1.09 (7.92%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Karyopharm Therapeutics Inc. stock A Buy?

Karyopharm Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.070 Sell Candidate Unchanged

Predicted Opening Price for Karyopharm Therapeutics Inc. of Wednesday, June 12, 2024

Fair opening price June 12, 2024 Current price
$0.99 ( 2.01%) $1.01

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KPTI

Fibonacci Support & Resistance Levels

Level Price
R3 1.08 7.00%
R2 1.05 3.55%
R1 1.02 1.43%
Price 1.01
S1 0.95 -5.45%
S2 0.93 -7.58%
S3 0.90 -11.02%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.13 11.88%
R2 1.10 8.91%
R1 1.09 7.92%
Price 1.01
S1 0.99 -1.54%
S2 0.99 -2.22%
S3 0.96 -4.72%

FAQ

What is the symbol for Karyopharm Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Karyopharm Therapeutics Inc. is KPTI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Karyopharm Therapeutics Inc. Stock?
Karyopharm Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Karyopharm Therapeutics Inc. Stock?
Karyopharm Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Karyopharm Therapeutics Inc. Stock.

What's the current price of Karyopharm Therapeutics Inc. Stock?
As of the end of day on the Jun 11, 2024, the price of an Karyopharm Therapeutics Inc. (KPTI) share was $1.01.

What is the 52-week high and low for Karyopharm Therapeutics Inc. Stock?
The 52-week high for Karyopharm Therapeutics Inc. Stock is $2.33 and the 52-week low is $0.617.

What is the market capitalization of Karyopharm Therapeutics Inc. Stock?
As of the Jun 11, 2024, the market capitalization of Karyopharm Therapeutics Inc. is 125.862M.

When is the next earnings date for Karyopharm Therapeutics Inc.?
The upcoming earnings date for Karyopharm Therapeutics Inc. is Aug 07, 2024.
Click to get the best stock tips daily for free!

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics. Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezo... KPTI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT